ASGCT 2024 Comes at Pivotal Time for Gene and Cell Therapy Sector

Jeffrey Chamberlain, president of the American Society of Gene & Cell Therapy, spoke with BioSpace about what we can expect to learn about in Baltimore this week.

Scroll to Top